Can fatty liver affect eyes? Whilst fatty liver disease does not directly damage the eyes, the metabolic conditions that accompany it—particularly type 2 diabetes, hypertension, and abnormal cholesterol—can significantly impact vision. Non-alcoholic fatty liver disease (NAFLD) affects approximately one in three UK adults, often occurring alongside diabetes, which is a leading cause of vision loss. Understanding the connection between liver health and eye complications helps you recognise warning signs early and protect your sight through comprehensive metabolic management.
Summary: Fatty liver disease does not directly cause eye damage, but the metabolic conditions that accompany it—especially type 2 diabetes—can significantly affect vision and eye health.
- Up to 70% of people with type 2 diabetes have non-alcoholic fatty liver disease (NAFLD), sharing common metabolic dysfunction.
- Diabetic retinopathy, caused by elevated blood glucose damaging retinal blood vessels, is the primary eye complication linked to the metabolic syndrome associated with fatty liver.
- Advanced liver disease can cause jaundice, visible as yellowing of the whites of the eyes, indicating significant liver impairment requiring urgent assessment.
- Managing underlying metabolic factors—weight, blood glucose, blood pressure, and cholesterol—benefits both liver and eye health simultaneously.
- People with NAFLD and diabetes should attend annual NHS Diabetic Eye Screening Programme appointments to detect retinal changes early.
Table of Contents
Understanding Fatty Liver Disease and Its Systemic Effects
Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells—specifically, when more than 5% of liver cells (hepatocytes) contain fat. This condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which affects individuals who drink little to no alcohol, and alcohol-related liver disease (ARLD), caused by excessive alcohol consumption. NAFLD has become increasingly common in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.
The liver performs over 500 vital functions, including filtering toxins from the blood, producing proteins essential for blood clotting, metabolising medications, and regulating blood sugar levels. In early NAFLD, liver function is usually preserved and blood tests may be normal. However, the condition can progress to more serious forms such as non-alcoholic steatohepatitis (NASH), where inflammation damages liver cells, potentially leading to fibrosis, cirrhosis, or liver failure.
Because the liver plays such a central role in metabolism and detoxification, advanced liver dysfunction can have systemic effects throughout the body. The liver's impaired ability to process nutrients, produce essential proteins, and eliminate toxins can affect multiple organ systems, including the cardiovascular system, kidneys, and potentially the eyes. Understanding these connections is crucial for recognising complications early and seeking appropriate medical intervention.
The progression of fatty liver disease varies considerably between individuals. Whilst some people maintain simple steatosis without progression, others develop inflammation and scarring. NICE guidelines (NG49) recommend assessing fibrosis risk using non-invasive scores such as FIB-4 or the NAFLD Fibrosis Score, followed by the Enhanced Liver Fibrosis (ELF) blood test if risk is indeterminate or high. Adults at low risk should have their fibrosis risk reassessed approximately every three years. Routine population screening for NAFLD is not recommended. Those with indeterminate or high fibrosis risk, or suspected advanced disease, should be referred to a hepatologist for specialist assessment.
Can Fatty Liver Affect Eyes? The Connection Explained
The relationship between fatty liver disease and eye health is indirect rather than direct. NAFLD does not directly cause a specific eye disease. However, the metabolic conditions that frequently accompany fatty liver disease—particularly type 2 diabetes, hypertension, and dyslipidaemia—can significantly affect vision and eye health.
Up to 70% of people with type 2 diabetes have NAFLD, whilst among people with NAFLD, approximately 15–30% have type 2 diabetes or impaired glucose tolerance. Diabetic retinopathy, a leading cause of vision loss in working-age adults in the UK, develops when persistently elevated blood glucose damages the small blood vessels in the retina. This complication affects the eyes through the same metabolic dysfunction that contributes to fatty liver disease, creating a shared pathophysiological pathway rather than a direct causative relationship.
Advanced liver disease, particularly cirrhosis, can affect the eyes through different mechanisms. When liver function deteriorates significantly, the accumulation of bilirubin causes jaundice, which manifests as yellowing of the sclera (the white part of the eye). This visible sign often prompts individuals to seek medical attention. In rare cases of advanced or decompensated liver disease, severe coagulation abnormalities may occur, though retinal complications from this are uncommon and not a routine clinical expectation.
The metabolic syndrome cluster—central obesity, insulin resistance, hypertension, and abnormal lipid levels—represents the common ground linking fatty liver disease and various eye conditions. Managing these underlying metabolic factors benefits both liver and eye health. People with NAFLD who also have diabetes should attend the NHS Diabetic Eye Screening Programme, which offers annual retinal photography for all people with diabetes aged 12 and over. Those without diabetes should have routine optometric examinations every two years, or more frequently if recommended by their optometrist.
Eye Symptoms and Complications Associated with Liver Disease
Whilst fatty liver disease in its early stages rarely causes eye symptoms, several ocular manifestations can occur as liver disease progresses or through associated metabolic conditions. Recognising these signs enables timely medical assessment and appropriate management.
Jaundice represents the most recognisable eye-related sign of liver dysfunction. When the liver cannot adequately process bilirubin—a yellow pigment produced during the breakdown of red blood cells—it accumulates in tissues, causing yellowing of the sclera. This typically indicates significant liver impairment and requires urgent same-day medical assessment. Jaundice may be accompanied by dark urine and pale stools, reflecting altered bilirubin metabolism.
Vision changes related to diabetes affect people with fatty liver disease primarily when they also have diabetes. These include:
-
Blurred vision from fluctuating blood glucose levels affecting the lens
-
Diabetic retinopathy, ranging from mild background changes to proliferative disease with new blood vessel formation
-
Diabetic macular oedema, causing central vision distortion
-
Increased risk of glaucoma and cataracts
In advanced cirrhosis with severe liver dysfunction, vitamin A deficiency may rarely occur, as the liver stores and processes this essential nutrient required for normal vision. Deficiency can lead to night blindness and, in severe cases, corneal damage, though this is uncommon in the UK. Important safety note: do not start vitamin A supplements without medical advice, as excess vitamin A can be harmful to the liver.
Xanthelasma—yellowish deposits of cholesterol around the eyelids—may occur in people with dyslipidaemia, a condition frequently associated with fatty liver disease. Whilst not affecting vision, these deposits indicate abnormal lipid metabolism and should prompt a lipid profile blood test and cardiovascular risk assessment according to NICE guidance. Additionally, some individuals with metabolic syndrome experience dry eyes or other ocular surface problems, though the connection to fatty liver disease specifically remains unclear.
When to Seek Medical Advice for Vision Changes
Knowing when to contact your GP or seek urgent care for vision changes is essential for preventing permanent damage and identifying underlying health problems, including liver disease progression.
Seek same-day urgent assessment (contact your GP for an urgent appointment or call NHS 111 if your GP is unavailable) if you experience:
- Yellowing of the whites of your eyes, particularly if accompanied by yellowing skin, dark urine, pale stools, or abdominal discomfort
Contact your GP promptly if you experience:
-
Gradual blurring of vision that doesn't improve with blinking or resting your eyes
-
Difficulty seeing in dim light or significant night vision problems
-
Distortion of straight lines or dark spots in your central vision
-
Persistent dry, gritty, or uncomfortable eyes
Seek immediate medical attention (call 999 or attend A&E) if you develop:
-
Sudden vision loss in one or both eyes
-
Sudden onset of floaters, flashes of light, or a curtain-like shadow across your vision (potential retinal detachment)
-
Severe eye pain with redness, nausea, or vomiting (possible acute glaucoma)
-
Double vision or vision loss accompanied by severe headache, confusion, or neurological symptoms
If you have been diagnosed with fatty liver disease and also have diabetes, you will be invited to the NHS Diabetic Eye Screening Programme, which offers retinal photography for all people with diabetes aged 12 and over. Screening is usually annual, though intervals may vary depending on findings. Even without diabetes, individuals with metabolic syndrome should have routine optometric examinations every two years, or more frequently if recommended by their optometrist.
Maintain open communication with your GP about both your liver condition and any vision concerns. Your healthcare team can coordinate care between hepatology, ophthalmology, and other specialties as needed, ensuring comprehensive management of interconnected health issues.
Managing Fatty Liver to Protect Your Overall Health
Effective management of fatty liver disease not only protects liver health but also reduces the risk of associated complications affecting the eyes, cardiovascular system, and overall wellbeing. NICE guidelines (NG49) emphasise lifestyle modification as the cornerstone of treatment for NAFLD.
Weight management represents the most effective intervention for fatty liver disease. Evidence demonstrates that losing 7–10% of body weight can significantly reduce liver fat, inflammation, and fibrosis. Gradual, sustainable weight loss through reduced calorie intake and increased physical activity is recommended. The NHS Weight Loss Plan and referral to specialist weight management services may be appropriate for some individuals.
Dietary modifications should focus on:
-
Reducing refined carbohydrates and added sugars, particularly sugar-sweetened beverages
-
Limiting saturated fats whilst incorporating healthy fats from sources like oily fish, nuts, and olive oil
-
Increasing fibre intake through vegetables, fruits, whole grains, and pulses
-
Following a Mediterranean-style diet, which evidence suggests benefits both liver health and cardiovascular risk
-
Moderating or eliminating alcohol consumption: UK Chief Medical Officers advise that to keep health risks from alcohol low, it is safest not to drink more than 14 units per week on a regular basis. Many people with NAFLD may benefit from abstinence or drinking well below this limit, as alcohol can accelerate disease progression even in non-alcoholic fatty liver disease
Regular physical activity improves insulin sensitivity, aids weight management, and directly reduces liver fat. UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic activity weekly, such as brisk walking, cycling, or swimming, combined with muscle-strengthening activities on at least two days per week.
Managing associated conditions is crucial. This includes:
-
Optimising diabetes control through medication, diet, and monitoring (protecting both liver and eyes)
-
Treating hypertension and dyslipidaemia according to NICE guidelines; statins are safe and should be used when clinically indicated to reduce cardiovascular risk in people with NAFLD
-
Fibrosis risk assessment using non-invasive scores (FIB-4 or NAFLD Fibrosis Score) initially, with Enhanced Liver Fibrosis (ELF) blood test if risk is indeterminate or high; adults at low risk should have their fibrosis risk reassessed approximately every three years
-
Referral to a hepatologist if fibrosis risk is indeterminate or high, if advanced fibrosis or cirrhosis is suspected, or if abnormal liver tests remain unexplained
Currently, no medications are specifically licensed in the UK for treating NAFLD, though research continues. Treatment focuses on managing underlying metabolic conditions and preventing disease progression. By addressing fatty liver disease comprehensively, you protect not only your liver but also reduce risks to your eyes, heart, kidneys, and overall health, improving long-term outcomes and quality of life.
Frequently Asked Questions
Can fatty liver disease cause vision problems?
Fatty liver disease does not directly cause vision problems, but the metabolic conditions that frequently accompany it—particularly type 2 diabetes, hypertension, and abnormal cholesterol—can significantly affect eye health. Diabetic retinopathy, which damages the small blood vessels in the retina, is the primary vision complication linked to the metabolic dysfunction shared with fatty liver disease.
What are the eye symptoms of liver disease?
The most recognisable eye symptom of liver disease is jaundice—yellowing of the whites of the eyes—which indicates significant liver impairment and requires urgent same-day medical assessment. Other eye-related issues in people with fatty liver disease typically stem from associated diabetes, including blurred vision, diabetic retinopathy, and increased risk of glaucoma and cataracts.
Does fatty liver affect your eyesight if you have diabetes?
If you have both fatty liver disease and diabetes, your eyesight is at risk primarily from diabetic complications rather than the liver condition itself. Up to 70% of people with type 2 diabetes have NAFLD, and diabetic retinopathy—caused by persistently elevated blood glucose damaging retinal blood vessels—is a leading cause of vision loss in working-age UK adults.
Should I get my eyes checked if I have a fatty liver?
If you have fatty liver disease and diabetes, you should attend the NHS Diabetic Eye Screening Programme, which offers annual retinal photography to detect diabetic retinopathy early. If you do not have diabetes, routine optometric examinations every two years are recommended, or more frequently if your optometrist advises, particularly if you have other metabolic syndrome components like hypertension or high cholesterol.
What's the difference between fatty liver symptoms and diabetic eye problems?
Early fatty liver disease typically causes no symptoms at all, whilst diabetic eye problems like retinopathy can cause blurred vision, floaters, or vision loss as they progress. The two conditions are connected through shared metabolic dysfunction—insulin resistance, obesity, and abnormal lipid levels—rather than one directly causing the other, which is why managing these underlying factors protects both liver and eye health.
When should I see a doctor about yellow eyes with fatty liver?
Yellowing of the whites of your eyes (jaundice) indicates significant liver impairment and requires same-day urgent medical assessment—contact your GP for an urgent appointment or call NHS 111 if your GP is unavailable. Jaundice is typically accompanied by other signs such as yellowing skin, dark urine, pale stools, or abdominal discomfort, and should never be ignored as it signals that your liver is not functioning properly.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript








